{"id":22,"date":"2022-02-18T14:18:36","date_gmt":"2022-02-18T05:18:36","guid":{"rendered":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/?page_id=22"},"modified":"2022-10-26T15:24:27","modified_gmt":"2022-10-26T06:24:27","slug":"research-achievement","status":"publish","type":"page","link":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/research-achievement\/","title":{"rendered":"\u7814\u7a76\u696d\u7e3e\u30fb\u8ad6\u6587"},"content":{"rendered":"\r\n

\u8ad6\u6587<\/h2>\r\n\r\n\r\n\r\n

\u7dcf\u8aac<\/h3>\r\n
    \r\n
  1. \u76f8\u6fa4\u60a0\u592a. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9. \u65e5\u672c\u65b0\u751f\u5150\u6210\u80b2\u533b\u5b66\u4f1a\u96d1\u8a8c 33: 18-22, 2021<\/li>\r\n
  2. Aizawa Y, Izumita R, Saitoh A. Human Parechovirus Type 3 Infection: An Emerging Infection in Neonates and Young Infants. J Infect Chemother<\/em> 23: 419-426, 2017<\/li>\r\n
  3. \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9. \u30a6\u30a4\u30eb\u30b9 \u7b2c65\u5dfb \u7b2c\uff11\u53f7:17-26, 2015<\/li>\r\n<\/ol>\r\n

    \u75ab\u5b66<\/h3>\r\n
      \r\n
    1. \u76f8\u6fa4\u60a0\u592a, \u592a\u5200\u5ddd\u6f64, \u5e7e\u7028\u6a39, \u7fbd\u6df1\u7406\u6075, \u9f4b\u85e4\u662d\u5f66, \u6e21\u9089\u9999\u5948\u5b50, \u8af8\u5ca1\u96c4\u4e5f, \u53e4\u91ce\u61b2\u53f8, \u6734\u5d07\u5a1f, \u6c34\u91ce\u7531\u7f8e, \u5ddd\u53e3\u76f4\u6a39, \u539f\u5353\u4e5f, \u7802\u5ddd\u5bcc\u6b63. \u798f\u5ca1\u770c\u30fb\u5927\u5206\u770c\u304b\u3089\u306e\u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306e\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u611f\u67d3\u75c7\u306e\u75c7\u4f8b\u96c6\u7a4d\u306e\u5831\u544a. IASR 43; 234-235, 2022<\/li>\r\n
    2. Aizawa Y, Kasamatsu T, Nagasawa K, Watanabe K, Saitoh A. Molecular Evolution and Epidemiology of Parechovirus-A3 in Japan, 1997-2019. J Infect Dis 2022 May 24: jiac213. Online ahead of print.<\/li>\r\n
    3. \u76f8\u6fa4\u60a0\u592a, \u9234\u6728\u512a\u5b50, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u3010\u82e5\u624b\u5968\u52b1\u8cde\u53d7\u8cde\u6f14\u984c\u3011\u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306e\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u20152014\u5e74\u65b0\u6f5f\u770c\u306e\u6d41\u884c\u304b\u3089\u2015. \u81e8\u5e8a\u3068\u30a6\u30a4\u30eb\u30b9 43(4): 206-212, 2015<\/li>\r\n
    4. \u76f8\u6fa4\u60a0\u592a, \u9234\u6728\u512a\u5b50, \u6e21\u9089\u9999\u5948\u5b50, \u5927\u77f3\u667a\u6d0b, \u9f4b\u85e4\u662d\u5f66. \uff1c\u901f\u5831\uff1e\u65b0\u6f5f\u770c\u306b\u304a\u3051\u308b\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306e\u60a3\u8005\u5831\u544a\u306e\u6025\u5897. IASR 35: 220, 2014<\/li>\r\n<\/ol>\r\n

      \u8a3a\u65ad<\/h3>\r\n
        \r\n
      1. Suzuki Y, Aizawa Y, Izumita R, Habuka R, Watanabe K, Saitoh A. PCR Detection Rates for Serum and Cerebrospinal Fluid from Neonates and Young Infants Infected with Human Parechovirus Type 3 and Enteroviruses. J Clin Virol <\/em>135:104736, 2021<\/li>\r\n
      2. Izumita R, Aizawa Y, Habuka R, Watanabe K, Otsuka T, Kitamura N, Akazawa K, Saitoh A. Novel Scoring System for Differentiating Parechovirus-A3 and Enterovirus Infection in Neonates and Young Infants. J Clin Virol <\/em>124: 104256, 2020<\/li>\r\n
      3. Aizawa Y, Koyama A, Ishihara T, Onodera O, Saitoh A. Performance of a Real-time PCR-based Approach and Droplet Digital PCR in Detecting Human Parechovirus Type 3 RNA. J Clin Virol <\/em>84: 27-31, 2016<\/li>\r\n
      4. Aizawa Y, Suzuki Y, Watanabe K, Oishi T, Saitoh A. Clinical Utility of Serum Samples for Human Parechovirus Type 3 Infection in Neonates and Young Infants: The 2014 Epidemic in Japan. J Infect<\/em> 72: 223-232, 2016<\/li>\r\n<\/ol>\r\n

        \u4f1d\u64ad<\/h3>\r\n
          \r\n
        1. Izumita R, Deuchi K, Aizawa Y, Habuka R, Watanabe K, Otsuka T, Saitoh A. Intrafamilial Transmission of Parechovirus A and Enteroviruses in Neonates and Young infants. J Pediatric Infect Dis Soc<\/em> 8: 501-506, 2019<\/li>\r\n
        2. Saitoh A. RE: “SEVERE HUMAN PARECHOVIRUS INFECTIONS IN INFANTS AND THE ROLE OF OLDER SIBLINGS”. Am J Epidemiol 184: 603-604, 2016<\/li>\r\n
        3. Aizawa Y, Yamanaka T, Watanabe K, Oishi T, Saitoh A. Asymptomatic Children Might Transmit Human Parechovirus Type 3 to Neonates and Young Infants. J Clin Virol<\/em> 70: 105-108, 2015<\/li>\r\n<\/ol>\r\n

          \u75c5\u614b\u751f\u7406<\/h3>\r\n
            \r\n
          1. Habuka R, Aizawa Y, Izumita R, Domon H, Terao Y, Takihara H, Okuda S, Saitoh A. Innate Immune Responses in Serum and Cerebrospinal Fluid from Neonates and Infants Infected with Parechovirus-A3 or Enteroviruses. J Infect Dis<\/em> 222: 681-689, 2020<\/li>\r\n
          2. \u7fbd\u6df1\u7406\u6075, \u76f8\u6fa4\u60a0\u592a, \u9234\u6728\u512a\u5b50, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306b\u304a\u3051\u308b\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u611f\u67d3\u75c7\u3068\u30a8\u30f3\u30c6\u30ed\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u81e8\u5e8a\u50cf\u306e\u9055\u3044\u3092\u3069\u3046\u8aac\u660e\u3059\u308b\u304b\uff1f\u2015\u81ea\u7136\u514d\u75ab\u306e\u89b3\u70b9\u304b\u3089\u30fc. \u81e8\u5e8a\u3068\u30a6\u30a4\u30eb\u30b9 48: 308-316, 2020<\/li>\r\n
          3. Nimura K, Maruyama Y, Aizawa Y, Saitoh A, Nakazawa Yozo. Changes in Laboratory Findings in Parechovirus-A Infection in Nine Neonates and Infants. Pediatr Int <\/em>62: 755-758, 2020<\/li>\r\n
          4. Izumita R, Aizawa Y, Watanabe K, Saitoh A. Persistence of High Neutralizing Antibody Titers after Neonatal and Early Infantile Infection with Parechovirus-A3. Pediatr Infect Dis J <\/em>38: e159-e161, 2019<\/li>\r\n
          5. Aizawa Y, Watanabe K, Oishi T, Hirano H, Hasegawa I, Saitoh A. Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 3. Emerg Infect Dis <\/em>21: 1966-1972, 2015<\/li>\r\n<\/ol>\r\n

            \u75c7\u4f8b\u5831\u544a<\/h3>\r\n
              \r\n
            1. Maki S, Aizawa Y, Ito Y, Suda M, Saitoh A. Acute Heart Failure due to Dilated Cardiomyopathy Exacerbated by Systemic Parechovirus-A1 Infection in an Infant. Int J Infect Dis<\/em> 104:273-275, 2021<\/li>\r\n
            2. Arai S, Yamanaka T, Kasai M, Fukuyama T, Aizawa Y, Matsui K, Sato M, Matsui H, Saitoh A. Parechovirus-A3 Encephalitis Presenting with Focal Seizure Mimicking Herpes Simplex Virus Infection. J Infect Chemother<\/em> 26: 736-740, 2020<\/li>\r\n
            3. \u4e2d\u5c71\u6709\u7f8e, \u76f8\u6fa4\u60a0\u592a, \u5927\u585a\u5cb3\u4eba, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b94\u578b\u306b\u3088\u308b\u6557\u8840\u75c7\u69d8\u75c7\u5019\u7fa4\u3092\u5448\u3057\u305f\u65b0\u751f\u5150\u306e1\u4f8b. \u5c0f\u5150\u611f\u67d3\u514d\u75ab 29: 259-262, 2017<\/li>\r\n
            4. \u8429\u539f\u79c0\u4fca, \u677e\u672c\u6d69, \u6a4b\u672c\u9038\u7f8e, \u85e4\u7530\u57fa\u8cc7, \u91ce\u6751\u667a\u7ae0, \u7530\u6751\u7fa9\u8f1d, \u8302\u6728\u967d, \u82e5\u677e\u592a, \u5ddd\u53e3\u88d5\u4e4b, \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66, \u91ce\u3005\u5c71\u6075\u7ae0. \u5927\u8133\u767d\u8cea\u969c\u5bb3\u3092\u8a8d\u3081\u305f\u65b0\u751f\u5150\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e2\u4f8b. \u65e5\u672c\u5c0f\u5150\u79d1\u5b66\u4f1a\u96d1\u8a8c 120: 1087-1093, 2016<\/li>\r\n
            5. Nirei J\u203b, Aizawa Y\u203b, Okazaki M, Kobayashi A, Onozuka J, Numata O, Oishi T, Saitoh A. Human Parechovirus Type 3 Infection: A Cause of Apnea in Infants Born Prematurely. Pediatr Int <\/em>58: 400-402, 2016
              \u203bequally contributed author<\/li>\r\n<\/ol>\r\n\r\n\r\n\r\n\r\n\r\n

              \u8457\u66f8<\/span><\/h2>\r\n\r\n\r\n\r\n
                \r\n
              1. \u76f8\u6fa4\u60a0\u592a. \u30a8\u30f3\u30c6\u30ed\u30a6\u30a4\u30eb\u30b9\u30fb\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9. \u7279\u5b9a\u306e\u5fae\u751f\u7269\u306b\u304a\u3051\u308b\u30de\u30cd\u30fc\u30b8\u30e1\u30f3\u30c8. \u5c0f\u5150\u6551\u547d\u6551\u6025\u30fbICU\u30d4\u30c3\u30af\u30a2\u30c3\u30d7\u611f\u67d3\u75c7 125-130, 2020<\/li>\r\n
              2. \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u5c0f\u5150\u5185\u79d1\u5897\u520a\u53f7 51; 727-730, 2019<\/li>\r\n
              3. \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u81e8\u5e8a\u3068\u5fae\u751f\u7269 46; 697-702, 2019<\/li>\r\n
              4. \u76f8\u6fa4\u60a0\u592a. 2\u30ab\u6708, \u5973\u5150, \u767a\u71b1. \u81e8\u5e8a\u5199\u771f\u56f3\u9451\u2015\u30b3\u30e2\u30f3\u306a\u75be\u60a3\u7de8 \u96c6\u307e\u308c\uff01\u3088\u304f\u307f\u308b\u75be\u60a3\u306e\u6ce8\u76ee\u6240\u898b. \u30ec\u30b8\u30c7\u30f3\u30c8\u30ce\u30fc\u30c8 21: 2027-2028, 2019<\/li>\r\n
              5. \u76f8\u6fa4\u60a0\u592a. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306e\u6d41\u884c\u306e\u6761\u4ef6. \u30c1\u30e3\u30a4\u30eb\u30c9\u30d8\u30eb\u30b9 22: 684-687, 2019<\/li>\r\n
              6. \u76f8\u6fa4\u60a0\u592a. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u5c0f\u5150\u79d1\u8a3a\u7642 51:733-737, 2019<\/li>\r\n
              7. \u76f8\u6fa4\u60a0\u592a. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u5c0f\u5150\u306e\u6cbb\u7642\u6307\u91dd. \u5c0f\u5150\u79d1\u8a3a\u76422018\u5e74\u5897\u520a\u53f7 178-180, 2018<\/li>\r\n
              8. \u6cc9\u7530\u4eae\u5e73, \u9f4b\u85e4\u662d\u5f66. \u56fd\u5185\u3067\u8a71\u984c\u306e\u611f\u67d3\u75c7\u2015\u8a3a\u65ad\u3068\u6cbb\u7642\u3000\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u5c0f\u5150\u5185\u79d1 49: 1651-1654, 2017<\/li>\r\n
              9. \u76f8\u6fa4\u60a0\u592a. 3\u304b\u6708\u9f62\u307e\u3067\u306e\u65b0\u751f\u5150\u3068\u4e73\u5150\u306b\u767a\u75c7\u3059\u308b\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7. \u30c1\u30e3\u30a4\u30eb\u30c9\u30d8\u30eb\u30b9 20: 48-50, 2017<\/li>\r\n
              10. \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u8ad6\u58c7. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u65e5\u672c\u5c0f\u5150\u79d1\u533b\u4f1a\u4f1a\u5831 51: 119-122, 2016<\/li>\r\n
              11. \u76f8\u6fa4\u60a0\u592a. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u65b0\u6f5f\u770c\u5c0f\u5150\u79d1\u533b\u4f1a\u4f1a\u5831 55:11-14, 2015<\/li>\r\n
              12. \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u691c\u67fb\u3068\u6280\u8853 43:1178-1181, 2015<\/li>\r\n
              13. \u76f8\u6fa4\u60a0\u592a. \u6ce8\u76ee\u306e\u611f\u67d3\u75c7\u2015\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u2015. Medical Technology 43:1028-1029, 2015<\/li>\r\n
              14. \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9. \u81e8\u5e8a\u533b\u306e\u305f\u3081\u306e\u547c\u5438\u5668\u30fb\u6d88\u5316\u7ba1\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u8a3a\u65ad\u3068\u6cbb\u7642\u793e: 16-20, 2014<\/li>\r\n<\/ol>\r\n\r\n\r\n\r\n

                \u56fd\u969b\u5b66\u4f1a\u767a\u8868<\/h2>\r\n\r\n\r\n\r\n
                  \r\n
                1. Aizawa Y, Izumita R, Yamanaka T, Habuka R, Ikuse T, Watanabe K, Otsuka T, Saitoh A. Changing Epidemiological Profile of Infantile Parechovirus-A3 Infection in Japan. ID week 2019 [Poster number: 2585]: Washington D.C., USA, 2019<\/li>\r\n
                2. Izumita R, Kon K, Aizawa Y, Watanabe K, Saitoh A. Human Breast Milk Inhibits the Replication of Parechovirus-A3. ID week 2019 [Poster number: 2586]: Washington DC., USA, 2019<\/li>\r\n
                3. Izumita R, Aizawa Y, Watanabe K, Saitoh A. Long-term Neurological Outcome and Neutralizing Antibody Titers against Paraechovirus-A3 (PeV-A3) in Children who Developed PeV-A3-Related Diseases in Neonatal and Infantile Periods. ID week 2018 [Poster number: 2349]: San Francisco, CA, USA, 2018.<\/li>\r\n
                4. Izumita R, Aizawa Y, Watanabe K, Saitoh A. Neutralizing Antibody Titers against Parechoivirus-A3 (PeV-A3) and Long-term Neurological Outcome in Children who Suffered from PeV-A3-Related Diseases in Neonatal and Infantile Periods. Asian Society for Pediatric Infectious Disease, 9th Asian Congress of Pediatric Infectious Diseases [Abstract number: 1134]: Fukuoka, Japan, 2018.<\/li>\r\n
                5. Izumita R, Aizawa Y, Habuka R, Watanabe K, Otsuka T, Saitoh A. Can We Distinguish between Human Parechovirus Type 3 and Enteroviruses Infection in Neonates and Young Infants Based on their Clinical and Laboratory Findings? ID week 2016 [Poster number: 2332]: San Diego, CA, USA, 2017.<\/li>\r\n
                6. Izumita R, Aizawa Y, Watanabe K, Saitoh A. Asymptomatic Adults and Children Can Transmit Human Parechoviruses and Enteroviruses\u00a0to Neonates and Young Infants. ID week 2017 [Poster number: 1474]: San Diego, CA, USA, 2017.<\/li>\r\n
                7. Izumita R, Aizawa Y, Habuka R, Watanabe K, Otsuka T, Saitoh A. A Role of Intravenous Immunoglobulin in Human Parechovirus Type 3 Infection in an in vitro<\/em> ID week 2016 [Poster number: 152]: New Orleans, LA, USA, 2016<\/li>\r\n
                8. Aizawa Y, Yamanaka T, Watanabe K, Oishi T, Saitoh A. Asymptomatic Children Might Transmit Human Parechovirus Type 3 to Neonates and Young Infants. ID week 2015 [Abstract: 51380]: San Diego, USA, 2015<\/li>\r\n
                9. Aizawa Y, Oishi T, Saitoh A. Skin mottling is a diagnostic clue of human parechovirus type 3 infection. 11th ASPR\/118th JPS Joint Poster Session [Abstract: JP-049]: Osaka, Japan, 2015<\/li>\r\n
                10. Aizawa Y, Watanabe K, Oishi T, Hirano H, Hasegawa I, Saitoh A. Role of maternal antibodies in human parechovirus type 3 infection in neonates and young infants. 11th Congress of Asian Society for Pediatric Research [Abstract: 1-AO-006]: Osaka, Japan, 2015<\/li>\r\n
                11. Aizawa Y, Watanabe K, Suzuki Y, Oishi T, Hirano H, Hasegawa I, Saitoh A. Role of Maternal Antibodies in Human Parechovirus Type 3 Infection in Young Infants. ID week 2014 [Abstract: 45981]: Philadelphia, USA, 2014<\/li>\r\n<\/ol>\r\n\r\n\r\n\r\n

                  \u56fd\u5185\u5b66\u4f1a\u767a\u8868<\/h2>\r\n\r\n\r\n\r\n
                    \r\n
                  1. \u76f8\u6fa4\u60a0\u592a. \u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306e\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u611f\u67d3\u75c7\u306e\u524d\u65b9\u8996\u7684\u75ab\u5b66\u8abf\u67fb\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09. \u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u6771\u4eac, 2022<\/li>\r\n
                  2. \u76f8\u6fa4\u60a0\u592a, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u65b0\u6f5f\u770c\u306b\u304a\u3051\u308b23\u5e74\u9593\u306e\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u306e\u5206\u5b50\u9032\u5316\u75ab\u5b66. \u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a\uff08web\u958b\u50ac\uff09, 2021<\/li>\r\n
                  3. \u6cc9\u7530 \u4eae\u5e73, \u76f8\u6fa4\u60a0\u592a, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u306b\u5bfe\u3059\u308b\u6bcd\u4e73\u306e\u6297\u30a6\u30a4\u30eb\u30b9\u52b9\u679c\u306e\u691c\u8a0e. \u7b2c52\u56de\u65e5\u672c\u5c0f\u5150\u611f\u67d3\u75c7\u5b66\u4f1a, \u5927\u962a\uff08web\u958b\u50ac\uff09, 2020<\/li>\r\n
                  4. \u76f8\u6fa4\u60a0\u592a. \u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u611f\u67d3\u75c7, Visual Diagnosis of Clinical Virology. \u7b2c61\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u65b0\u6f5f(Web\u958b\u50ac), 2020<\/li>\r\n
                  5. \u76f8\u6fa4\u60a0\u592a, \u5b87\u7530\u548c\u5b8f, \u4f0a\u85e4\u5065\u592a, \u5e84\u53f8\u5065\u4ecb, \u5927\u7af9\u6b63\u609f\u3001\u7b20\u4e95\u6b63\u5fd7\u3001\u9234\u6728\u512a\u5b50, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u56fd\u5185\u306e\u5c0f\u5150\u5165\u9662\u65bd\u8a2d\u306b\u304a\u3051\u308b\u65b0\u751f\u5150\u3001\u65e9\u671f\u4e73\u5150\u306e\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u611f\u67d3\u75c7\u306e\u524d\u65b9\u8996\u7684\u75ab\u5b66\u8abf\u67fb\u2015\u7b2c1\u5831. \u7b2c61\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u65b0\u6f5f(Web\u958b\u50ac), 2020<\/li>\r\n
                  6. \u9234\u6728\u512a\u5b50, \u76f8\u6fa4\u60a0\u592a, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u306b\u5bfe\u3059\u308b\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u30fb\u30da\u30d7\u30c1\u30c9\u6cbb\u7642\u85ac\u306e\u52b9\u679c\u306e\u691c\u8a0e. \u7b2c61\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u65b0\u6f5f(Web\u958b\u50ac), 2020<\/li>\r\n
                  7. \u76f8\u6fa4\u60a0\u592a\u3001\u5ddd\u53e3\u76f4\u6a39\u3001\u5b87\u7530\u548c\u5b8f\u3001\u8239\u6728\u5b5d\u5247\u3001\u7b20\u4e95\u6b63\u5fd7\u3001\u5742\u7530\u664b\u53f2\u3001\u53e4\u91ce\u61b2\u53f8\u3001\u9f4b\u85e4\u662d\u5f66. 2019\u5e74\u306e\u56fd\u5185\u306b\u304a\u3051\u308b\u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306e\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u5e83\u304c\u308a. \u7b2c123\u56de\u65e5\u672c\u5c0f\u5150\u79d1\u5b66\u4f1a, \u795e\u6238(Web\u53c2\u52a0), 2020<\/li>\r\n
                  8. \u9234\u6728\u512a\u5b50, \u76f8\u6fa4\u60a0\u592a, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306b\u304a\u3051\u308b\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9A3\u3068\u30a8\u30f3\u30c6\u30ed\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7-\u8840\u6e05\u3068\u9ac4\u6db2PCR\u967d\u6027\u7387\u306e\u6bd4\u8f03. \u7b2c60\u56de\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u540d\u53e4\u5c4b, 2019<\/li>\r\n
                  9. Aizawa Y, Izumita R, Yamanaka T, Habuka R, Ikuse T, Otsuka T, Saitoh A. Epidemiological Changes in Young Infants with Parechovirus-A3 infection. The 122nd Annual Meeting of the Japan Pediatric Society, Kanazawa, Japan, 2019<\/li>\r\n
                  10. \u6cc9\u7530 \u4eae\u5e73, \u76f8\u6fa4\u60a0\u592a, \u7fbd\u6df1\u7406\u6075, \u6e21\u9089\u9999\u5948\u5b50, \u5927\u585a\u5cb3\u4eba, \u9f4b\u85e4\u662d\u5f66. \u65b0\u751f\u5150\u3068\u65e9\u671f\u4e73\u5150\u306b\u304a\u3051\u308b\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u3068\u30a8\u30f3\u30c6\u30ed\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u81e8\u5e8a\u50cf\u306e\u9055\u3044. \u7b2c49\u56de\u65e5\u672c\u5c0f\u5150\u611f\u67d3\u75c7\u5b66\u4f1a, \u91d1\u6ca2, 2017<\/li>\r\n
                  11. \u6cc9\u7530 \u4eae\u5e73, \u76f8\u6fa4\u60a0\u592a, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306b\u304a\u3051\u308b\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u3068\u30a8\u30f3\u30c6\u30ed\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u5bb6\u65cf\u5185\u4f1d\u64ad\u306e\u691c\u8a0e. \u7b2c49\u56de\u65e5\u672c\u5c0f\u5150\u611f\u67d3\u75c7\u5b66\u4f1a, \u91d1\u6ca2, 2017<\/li>\r\n
                  12. \u9234\u6728\u512a\u5b50, \u6e21\u9089\u9999\u5948\u5b50, \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u8840\u6e05\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u30a6\u30a4\u30eb\u30b9\u91cf\u3068\u5150\u306e\u672b\u68a2\u5faa\u74b0\u4e0d\u5168\u306e\u95a2\u9023. \u7b2c59\u56de\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u5927\u5bae, 2017<\/li>\r\n
                  13. \u6cc9\u7530\u4eae\u5e73, \u7fbd\u6df1\u7406\u6075, \u5927\u585a\u5cb3\u4eba, \u9f4b\u85e4\u662d\u5f66. \u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306b\u304a\u3051\u308b\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306e\u5bb6\u65cf\u5185\u4f1d\u64ad\u691c\u8a0e. \u7b2c120\u56de\u65e5\u672c\u5c0f\u5150\u79d1\u5b66\u4f1a, \u6771\u4eac, 2017<\/li>\r\n
                  14. \u6cc9\u7530\u4eae\u5e73, \u76f8\u6fa4\u60a0\u592a, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u306b\u5bfe\u3059\u308b\u30d2\u30c8\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u306ein vitro<\/em>\u306b\u304a\u3051\u308b\u52b9\u679c. \u7b2c48\u56de\u65e5\u672c\u5c0f\u5150\u611f\u67d3\u75c7\u5b66\u4f1a, \u5ca1\u5c71, 2016<\/li>\r\n
                  15. \u76f8\u6fa4\u60a0\u592a. \u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u5c0f\u5150\u306e\u65b0\u8208\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u300d\uff1a\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b. \u7b2c65\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u6771\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a, \u65b0\u6f5f, 2016<\/li>\r\n
                  16. Aizawa Y. Human Parechovirus Type 3 Infection in Neonates and Young Infants. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068\u547c\u5438\u5668\u30a6\u30a4\u30eb\u30b9\u30bb\u30df\u30ca\u30fcExchange Meeting in Niigata 2016, \u65b0\u6f5f, 2016<\/li>\r\n
                  17. \u76f8\u6fa4\u60a0\u592a, \u9f4b\u85e4\u662d\u5f66. \u4e73\u5150\u671f\u65e9\u671f\u306e\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306b\u304a\u3051\u308b\u79fb\u884c\u6297\u4f53\u306e\u5f79\u5272. \u5e73\u621027\u5e74\u5ea6\u4e2d\u90e8\u4e73\u9178\u83cc\u7814\u7a76\u4f1a, \u65b0\u6f5f, 2015<\/li>\r\n
                  18. \u76f8\u6fa4\u60a0\u592a,\u5c71\u4e2d\u5d07\u4e4b, \u6e21\u9089\u9999\u5948\u5b50, \u5927\u77f3\u667a\u6d0b, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306e\u4f1d\u64ad\u7d4c\u8def\u306e\u691c\u8a0e\u2015\u7121\u75c7\u72b6\u306e\u5b50\u3069\u3082\u304b\u3089\u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u3078\u306e\u53ef\u80fd\u6027\u2015. \u7b2c47\u56de\u65e5\u672c\u5c0f\u5150\u611f\u67d3\u75c7\u5b66\u4f1a, \u798f\u5cf6, 2015<\/li>\r\n
                  19. \u6751\u5c71\u6709\u7f8e\u3001\u7530\u4e2d\u7be4\u3001\u6e21\u8fba\u5065\u4e00\u3001\u76ee\u9ed2\u8302\u6a39\u3001\u7530\u4e2d\u96c5\u4eba\u3001\u76f8\u6fa4\u60a0\u592a\u3001\u6e21\u9089\u9999\u5948\u5b50\u3001\u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b94\u578b\u306b\u3088\u308b\u6557\u8840\u75c7\u69d8\u75c7\u72b6\u3092\u5448\u3057\u305f\u65b0\u751f\u5150\u306e1\u4f8b. \u7b2c47\u56de\u65e5\u672c\u5c0f\u5150\u611f\u67d3\u75c7\u5b66\u4f1a, \u798f\u5cf6, 2015<\/li>\r\n
                  20. \u76f8\u6fa4\u60a0\u592a, \u9234\u6728\u512a\u5b50, \u6e21\u9089\u9999\u5948\u5b50, \u9f4b\u85e4\u662d\u5f66. 2014\u5e74\u65b0\u6f5f\u770c\u306b\u304a\u3051\u308b\u65b0\u751f\u5150\u30fb\u65e9\u671f\u4e73\u5150\u306e\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306e\u6d41\u884c. \u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u5ca1\u5c71, 2015<\/li>\r\n
                  21. \u897f\u8107 \u4e16\u5948, \u9234\u6728 \u512a\u5b50, \u76f8\u6fa4 \u60a0\u592a, \u6e21\u9089 \u9999\u5948\u5b50, \u9f4b\u85e4 \u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9\u306e\u30b2\u30ce\u30e0\u907a\u4f1d\u5b50\u7d44\u63db\u3048\uff08Gene Recombination\uff09\u3068\u81e8\u5e8a\u50cf\u306e\u95a2\u9023\u306e\u691c\u8a0e. \u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u5ca1\u5c71, 2015<\/li>\r\n
                  22. \u76f8\u6fa4\u60a0\u592a. \u30d9\u30fc\u30b7\u30c3\u30af\u30ec\u30af\u30c1\u30e3\u30fc6\uff1a\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306e\u6700\u65b0\u306e\u77e5\u898b. \u7b2c89\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a, \u4eac\u90fd, 2015<\/li>\r\n
                  23. \u76f8\u6fa4\u60a0\u592a, \u9234\u6728\u512a\u5b50, \u5927\u77f3\u667a\u6d0b, \u9f4b\u85e4\u662d\u5f66. 2014\u5e74\u306b\u304a\u3051\u308b\u65b0\u6f5f\u770c\u3067\u306e\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306e\u6d41\u884c. \u7b2c218\u56de\u65e5\u672c\u5c0f\u5150\u79d1\u5b66\u4f1a\u65b0\u6f5f\u5730\u65b9\u4f1a\uff0c\u65b0\u6f5f\u5e02\uff0c2014<\/li>\r\n
                  24. \u76f8\u6fa4\u60a0\u592a, \u6e21\u9089\u9999\u5948\u5b50, \u5927\u77f3\u667a\u6d0b, \u5e73\u91ce\u6625\u4f38, \u9577\u8c37\u5ddd\u529f, \u9f4b\u85e4\u662d\u5f66. \u4e73\u5150\u671f\u65e9\u671f\u306e\u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306b\u304a\u3051\u308b\u79fb\u884c\u6297\u4f53\u306e\u5f79\u5272. \u7b2c46\u56de\u65e5\u672c\u5c0f\u5150\u611f\u67d3\u75c7\u5b66\u4f1a, \u6771\u4eac, 2014<\/li>\r\n
                  25. \u76f8\u6fa4\u60a0\u592a, \u6961\u4e95\u6df3, \u6e21\u9089\u9999\u5948\u5b50, \u9234\u6728\u512a\u5b50, \u5927\u77f3\u667a\u6d0b, \u9f4b\u85e4\u662d\u5f66. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b93\u578b\u611f\u67d3\u75c7\u306b\u3088\u308b\u65e9\u7523\u5150\u306e\u7121\u547c\u5438\u767a\u4f5c. \u7b2c55\u56de\u65e5\u672c\u81e8\u5e8a\u30a6\u30a4\u30eb\u30b9\u5b66\u4f1a, \u672d\u5e4c, 2014<\/li>\r\n<\/ol>\r\n","protected":false},"excerpt":{"rendered":"

                    \u8ad6\u6587 \u7dcf\u8aac \u76f8\u6fa4\u60a0\u592a. \u30d2\u30c8\u30d1\u30ec\u30b3\u30a6\u30a4\u30eb\u30b9. \u65e5\u672c\u65b0\u751f\u5150\u6210\u80b2\u533b\u5b66\u4f1a\u96d1\u8a8c 33: 18-22, 2021 Aizawa Y, Izumita R, Saitoh A. Human Parechovirus Type 3 I […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-22","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/pages\/22","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/comments?post=22"}],"version-history":[{"count":10,"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/pages\/22\/revisions"}],"predecessor-version":[{"id":129,"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/pages\/22\/revisions\/129"}],"wp:attachment":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/ped\/parechovirus\/wp-json\/wp\/v2\/media?parent=22"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}